• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与卵巢癌相关的流行病学和遗传因素。

Epidemiological and genetic factors associated with ovarian cancer.

作者信息

McLemore Monica R, Miaskowski Christine, Aouizerat Bradley E, Chen Lee-May, Dodd Marylin J

机构信息

Department of Physiologic Nursing, School of Nursing, University of California, San Francisco, 520 Frederick St, 31, San Francisco, CA 94117, USA.

出版信息

Cancer Nurs. 2009 Jul-Aug;32(4):281-8; quiz 289-90. doi: 10.1097/NCC.0b013e31819d30d6.

DOI:10.1097/NCC.0b013e31819d30d6
PMID:19444085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2891150/
Abstract

The purpose of this article was to provide a comprehensive review of the epidemiological and genetic factors associated with ovarian cancer. A more complete understanding of the determinants of ovarian cancer may lead to the development of better screening and detection methods for this disease. The first section of this article reviews current literature on screening and early detection of ovarian cancer. The second section reviews the epidemiology of ovarian cancer, specifically highlighting the risk factors associated with the development of this disease. The article concludes with a discussion of how oncology nurses can apply this information to improve patient care.

摘要

本文的目的是全面综述与卵巢癌相关的流行病学和遗传因素。对卵巢癌决定因素更全面的了解可能会促使开发出针对该疾病更好的筛查和检测方法。本文的第一部分综述了关于卵巢癌筛查和早期检测的当前文献。第二部分综述了卵巢癌的流行病学,特别强调了与该疾病发生相关的风险因素。本文最后讨论了肿瘤学护士如何应用这些信息来改善患者护理。

相似文献

1
Epidemiological and genetic factors associated with ovarian cancer.与卵巢癌相关的流行病学和遗传因素。
Cancer Nurs. 2009 Jul-Aug;32(4):281-8; quiz 289-90. doi: 10.1097/NCC.0b013e31819d30d6.
2
Advances in the early detection of ovarian cancer: How to hear the whispers early.卵巢癌早期检测的进展:如何尽早察觉细微迹象。
Nurs Womens Health. 2010 Jun;14(3):222-34. doi: 10.1111/j.1751-486X.2010.01543.x.
3
Designing early detection programs for ovarian cancer.设计卵巢癌早期检测项目。
J Natl Cancer Inst. 2010 Jan 6;102(1):3-4. doi: 10.1093/jnci/djp450. Epub 2009 Dec 30.
4
Symptoms and diagnostic delay in ovarian cancer: a summary of the literature.卵巢癌的症状与诊断延误:文献综述
Contemp Nurse. 2009;34(1):55-65. doi: 10.5172/conu.2009.34.1.055.
5
Ovarian cancer screening and prevention.卵巢癌筛查与预防
Semin Oncol Nurs. 2002 Aug;18(3):167-73. doi: 10.1053/sonu.2002.34077.
6
Early detection of ovarian cancer.卵巢癌的早期检测
CA Cancer J Clin. 1995 Mar-Apr;45(2):71-87. doi: 10.3322/canjclin.45.2.71.
7
Recognizing the subtle signs of ovarian cancer.识别卵巢癌的细微迹象。
Johns Hopkins Med Lett Health After 50. 2013 Apr;25(2):6.
8
Screening for ovarian cancer in the general population.普通人群中的卵巢癌筛查。
Best Pract Res Clin Obstet Gynaecol. 2012 Apr;26(2):243-56. doi: 10.1016/j.bpobgyn.2011.11.006. Epub 2011 Dec 17.
9
US cancer groups highlight symptoms of early ovarian cancer.美国癌症组织强调早期卵巢癌的症状。
BMJ. 2007 Jun 23;334(7607):1290-1. doi: 10.1136/bmj.39251.412870.DB.
10
Certain symptoms may be early signs of ovarian cancer.某些症状可能是卵巢癌的早期迹象。
Harv Womens Health Watch. 2007 Sep;15(1):6.

引用本文的文献

1
Developments in Genetics: Better Management of Ovarian Cancer Patients.遗传学的发展:更好地管理卵巢癌患者。
Int J Mol Sci. 2023 Nov 5;24(21):15987. doi: 10.3390/ijms242115987.
2
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer.高脂肪饮食和肥胖与上皮性卵巢癌中血管生成基因表达的差异有关。
Gynecol Oncol. 2023 Dec;179:97-105. doi: 10.1016/j.ygyno.2023.11.002. Epub 2023 Nov 11.
3
Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer.复制压力和有缺陷的检查点使输卵管上皮细胞成为高级别浆液性卵巢癌的潜在驱动因素。
Cell Rep. 2023 Oct 31;42(10):113144. doi: 10.1016/j.celrep.2023.113144. Epub 2023 Sep 19.
4
Patterns of Treatment and Outcomes in Epithelial Ovarian Cancer: A Retrospective North Indian Single-Institution Experience.上皮性卵巢癌的治疗模式和结局:印度北部单中心回顾性经验。
JCO Glob Oncol. 2022 Nov;8:e2200032. doi: 10.1200/GO.22.00032.
5
Ovarian cancer health politics in Romania and Germany: A comparative study.罗马尼亚和德国的卵巢癌健康政策:一项比较研究。
Exp Ther Med. 2021 Nov;22(5):1217. doi: 10.3892/etm.2021.10651. Epub 2021 Aug 26.
6
The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer.新辅助化疗和间隔减瘤手术对卵巢癌患者身体成分的影响。
JCSM Clin Rep. 2021 Jan;6(1):11-16. Epub 2020 Nov 11.
7
Induction of apoptosis on ovarian adenocarcinoma cells, A2780 by tricyclohexylphosphanegold (I) mercaptobenzoate derivatives via intrinsic and extrinsic pathways.三环己基膦金(I)巯基苯甲酸酯衍生物通过内源性和外源性途径诱导卵巢腺癌细胞A2780凋亡。
J Biol Inorg Chem. 2021 Oct;26(7):833-853. doi: 10.1007/s00775-021-01892-6. Epub 2021 Sep 3.
8
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).多学科方法仍然是改善和加强卵巢癌管理的最佳策略(综述)。
Int J Oncol. 2021 Jul;59(1). doi: 10.3892/ijo.2021.5233. Epub 2021 Jun 16.
9
Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells.含苯并稠合巯基吡啶的有机钌配合物克服卵巢癌细胞中的铂耐药性。
Cancers (Basel). 2021 May 20;13(10):2493. doi: 10.3390/cancers13102493.
10
MassArray analysis of genomic susceptibility variants in ovarian cancer.卵巢癌基因组易感性变异的 MassArray 分析。
Sci Rep. 2020 Dec 3;10(1):21101. doi: 10.1038/s41598-020-76491-7.

本文引用的文献

1
Hereditary ovarian cancer.遗传性卵巢癌
Crit Rev Oncol Hematol. 2009 Jan;69(1):28-44. doi: 10.1016/j.critrevonc.2008.06.003. Epub 2008 Jul 24.
2
Combining a symptoms index with CA 125 to improve detection of ovarian cancer.将症状指数与CA 125相结合以提高卵巢癌的检测率。
Cancer. 2008 Aug 1;113(3):484-9. doi: 10.1002/cncr.23577.
3
Cancer killer may be "silent" no more.癌症杀手可能不再“沉默”。
J Natl Cancer Inst. 2007 Sep 19;99(18):1359-61. doi: 10.1093/jnci/djm163. Epub 2007 Sep 11.
4
Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.遗传性妇科癌症:鉴别诊断、监测、管理及手术预防
Fam Cancer. 2008;7(1):53-8. doi: 10.1007/s10689-007-9144-x. Epub 2007 Jul 17.
5
Development of an ovarian cancer symptom index: possibilities for earlier detection.卵巢癌症状指数的开发:早期检测的可能性
Cancer. 2007 Jan 15;109(2):221-7. doi: 10.1002/cncr.22371.
6
Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.预防性子宫切除术在遗传性癌症高危患者中的作用。
Gynecol Oncol. 2006 Sep;102(3):475-9. doi: 10.1016/j.ygyno.2006.01.006. Epub 2006 Feb 13.
7
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.前列腺、肺癌、结直肠癌和卵巢癌(PLCO)筛查试验中的卵巢癌筛查:一项随机试验初始筛查的结果
Am J Obstet Gynecol. 2005 Nov;193(5):1630-9. doi: 10.1016/j.ajog.2005.05.005.
8
Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women.瑞典女性的一些生活方式因素与侵袭性上皮性卵巢癌风险
Eur J Epidemiol. 2004;19(11):1011-9. doi: 10.1007/s10654-004-1633-8.
9
Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.预防BRCA基因携带者患乳腺癌和卵巢癌:预防性手术的原理及监测的前景
Ann Surg Oncol. 2004 Dec;11(12):1030-4. doi: 10.1245/ASO.2004.09.910. Epub 2004 Nov 15.
10
Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort.瑞典乳腺X线摄影队列研究中的牛奶和乳糖摄入量与卵巢癌风险
Am J Clin Nutr. 2004 Nov;80(5):1353-7. doi: 10.1093/ajcn/80.5.1353.